Literature DB >> 29560881

Neuroimaging Intermediate Phenotypes of Executive Control Dysfunction in Schizophrenia.

Grant Sutcliffe1, Anais Harneit2, Heike Tost2, Andreas Meyer-Lindenberg2.   

Abstract

Genetic risk for schizophrenia is associated with impairments in the initiation and performance of executive control of cognition and action. The nature of these impairments and of the neural dysfunction that underlies them has been extensively investigated using experimental psychology and neuroimaging methods. In this article, we review schizophrenia-associated functional connectivity and activation abnormalities found in subjects performing experimental tasks that engage different aspects of executive function, such as working memory, cognitive control, and response inhibition. We focus on heritable traits associated with schizophrenia risk (intermediate phenotypes or endophenotypes) that have been revealed using imaging genetics approaches. These data suggest that genetic risk for schizophrenia is associated with dysfunction in systems supporting the initiation and application of executive control in neural circuits involving the anterior cingulate and dorsolateral prefrontal cortex. This article discusses current findings and limitations and their potential relevance to symptoms and disease pathogenesis.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive control; Endophenotypes; Executive function; Review; fMRI; n-back

Year:  2016        PMID: 29560881     DOI: 10.1016/j.bpsc.2016.03.002

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  5 in total

1.  Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia.

Authors:  Lucy D Vanes; Elias Mouchlianitis; Krisna Patel; Erica Barry; Katie Wong; Megan Thomas; Timea Szentgyorgyi; Dan Joyce; Sukhwinder Shergill
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

2.  Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes.

Authors:  Chuanjun Zhuo; Hongjun Tian; Jiayue Chen; Qianchen Li; Lei Yang; Qiuyu Zhang; Guangdong Chen; Langlang Cheng; Chunhua Zhou; Xueqin Song
Journal:  Front Genet       Date:  2022-08-19       Impact factor: 4.772

Review 3.  The neuropsychopharmacology of cannabis: A review of human imaging studies.

Authors:  Michael A P Bloomfield; Chandni Hindocha; Sebastian F Green; Matthew B Wall; Rachel Lees; Katherine Petrilli; Harry Costello; M Olabisi Ogunbiyi; Matthijs G Bossong; Tom P Freeman
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

4.  Amygdala hyperreactivity to faces conditioned with a social-evaluative meaning- a multiplex, multigenerational fMRI study on social anxiety endophenotypes.

Authors:  Janna Marie Bas-Hoogendam; Henk van Steenbergen; Nic J A van der Wee; P Michiel Westenberg
Journal:  Neuroimage Clin       Date:  2020-03-16       Impact factor: 4.881

Review 5.  The Construct of Medical and Non-Medical Marijuana-Critical Review.

Authors:  Andrzej Silczuk; Daria Smułek; Marcin Kołodziej; Julia Gujska
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.